ripekg:evaluation/RIPEAF2CE02F77A929431 |
prov:used |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAF2CE02F77A929431 |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAF2CE02F77A929431 |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
ripe:concerns |
ripekg:work/10.1002%2Foby.24316Secondary analysis of the Game of Stones trial for men with obesity: examining moderator effects and exploratory outcomes |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
ripe:recruitmentEndDateExtractionRationale |
No explicit end-of-recruitment date after full search. |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
ripe:recruitmentStartDate |
07-2021 |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
ripe:recruitmentStartDateExtractionRationale |
Methods: '...clinical trial conducted between July 2021 and July 2023...' Used start of conducted range as recruitment_start per rule 5; no specific FPI elsewhere. |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
ripe:studyEndDate |
07-2023 |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
ripe:studyEndDateExtractionRationale |
Methods: '...clinical trial conducted between July 2021 and July 2023...' Used end of conducted range as study_end_date per rule 5; no specific completion date. |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF2CE02F77A929431-human-2-2 |
ripekg:study-design-evidence/RIPEAF2CE02F77A929431 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF2CE02F77A929431-inspectai-2-2 |